Skip to content
Conference

Meet us at Anglonordic Life Science conference 2024

Looking for new investment or partnership opportunities? Denmark is ranked among the best countries in Europe for development of biotechnology, medtech and digital health. We are ready to help your company look at investment, business or research opportunities in Denmark. 
When 17.04.2024 - 18.04.2024
What
Life Sciences Pharma & Biotech

Conference information

When?

17-18 April: Conference at The County Hall, London @ etc.venues - (3rd floor)

Where?

London

Programme?

Find the complete programme on the conference's website.

More information can be found here.

Get an invitation Sign up for Anglonordic through Invest in Denmark

The Anglonordic Life Science Conference has a "by-invitation-only" policy. To request an invitation please reach out to Invest in Denmark's advisor Berit Chavez Azeri by clicking the link and fill out the form.
Get an invitation for Anglonordic here

Get to know Denmark's world-leading life science hub

Whether your company is looking for R&D collaborations, licensing, direct investment or expansion opportunities, Denmark has much to offer as with significant strongholds in biotech, medtech and digital health.

Whether your company is looking for R&D collaborations, licensing, direct investment or expansion opportunities, Denmark has much to offer as with significant strongholds in biotech, medtech and digital health.

Denmark is one of the most R&D intensive countries in the world and the best in Europe in terms of researcher concentration. Overall, Denmark has the 3rd largest commercial drug development pipeline in Europe. On a per capita basis, we have the world’s highest percentage of patents in biotechnology and the highest number of biotech companies. Denmark is also the country that conducts the most clinical trials per capita.

Denmark is one of the most R&D intensive countries in the world and the best in Europe in terms of researcher concentration. Overall, Denmark has the 3rd largest commercial drug development pipeline in Europe. On a per capita basis, we have the world’s highest percentage of patents in biotechnology and the highest number of biotech companies. Denmark is also the country that conducts the most clinical trials per capita.

With access to specialised talent and a highly productive and innovative biotech industry, Denmark is a very attractive location to invest in and place your research activities. 

Join us at AngloNordic How can we help you?

Come and chat with us at Anglonordic Life Science Conference 2024 to discuss how Invest in Denmark can help you. We assist foreign companies who are considering to invest or establish business or research activities in Denmark, all free of charge and in full confidentiality. 

Our services to investors, biotech, medtech or digital health companies include:

✔️ Facilitating contact with potential partners, public authorities and research institutions.

✔️ Targeted introductions and sourcing for investors including drug pipeline overview and introductions to other investors for potential syndicated investments

✔️ Tailored solutions for locating your project, business or research activities in Denmark

✔️ Information and analysis relevant to establishing business activities in Denmark

✔️ For more information please contact Berit Chavez Azeri on [email protected]

 

Our services to Danish biotech, medtech or digital health companies

✔️ Attend AngloNordic Life Science conference as part of a broader programme helping you scale to the UK or find strategic investors

✔️ For more information please contact Ilana Krasnik from the Trade Council on [email protected]

Choose Denmark because...

  • Denmark offers therapeutic areas of excellence in metabolic diseases, central nervous system, oncology and inflammatory and infectious diseases – as part of Medicon Valley, a strong healthcare research community and one of Europe’s strongest life science clusters. We provide access to a highly skilled talent pool and academic institutions of proven excellence, world-class patient registries, civil registries and biobanks, as well as excellent infrastructure including the world’s leading centre for life sciences and materials research: ESS and MAX IV.

  • The Danish medical technology industry is also one of the largest in the world measured in exports per capita, with more than 95% of all revenues generated abroad. With global leading companies in consumables, hearing aids and diabetes management devices, the Danish medtech sector is sustained by strong innovation and product R&D with a particular stronghold in diagnostics. 

  • Denmark also offers excellent conditions for developing digital health solutions with access to large amounts of longitudinal, linkable data from centralized health databases, biobanks and registries and socio-economic data from the entire Danish population. Combined with a long tradition of user-centred service and product design as well as a tech-savvy population, this makes Denmark ideal for research projects and testing product performance.

 

what is the AngloNordic life science conference

Anglonordic is the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.

The one-day conference provides exceptional value through panel discussions, parallel technology and biotech investment rooms and one-to-one meetings.

Take a deep dive into the Danish world-leading biotech industry

As an international hub for life sciences, Denmark offers foreign companies a respected international health laboratory. A politically favourable climate to the life science industry, a world-class research environment, and a strong, ambitious, and innovative life science cluster with a highly skilled labour pool, all supports the establishment of your life science business in Denmark. 

Click here

Would you like to meet us?

Please use the event app/matchmaking tool to book a meeting or reach out directly to our dedicated advisor:
Loading...